China Universal Asset Management »

Y Mabs Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $74k 9.5k 7.83
2024-09-30 $113k 8.6k 13.15
2024-06-30 $62k 5.2k 12.08
2024-03-31 $136k 8.4k 16.26
2023-12-31 $34k 5.1k 6.82
2022-09-30 $6.0k 410 14.63

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Caligan Partners
State Street Corporation
Logos Global Management
Geode Capital Management
Boothbay Fund Management
Pictet Asset Management Holding SA
D. E. Shaw & Co
Dimensional Fund Advisors
Cormorant Asset Management
Northern Trust

View all funds holding Y Mabs Therapeutics